You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 57 No. 4, April 2000 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (106)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Psychiatry, Other
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Structural Abnormalities of Subicular Dendrites in Subjects With Schizophrenia and Mood Disorders

Preliminary Findings

Gorazd Rosoklija, MD, PhD; Glen Toomayan, BS; Steven P. Ellis, PhD; John Keilp, PhD; J. John Mann, MD; Norman Latov, MD, PhD; Arthur P. Hays, MD; Andrew J. Dwork, MD

Arch Gen Psychiatry. 2000;57:349-356.

Background  Postmortem studies of the subiculum from subjects with schizophrenia have detected smaller pyramidal cell bodies and diminished immunoreactivity for the dendritic protein, microtubule-associated protein 2. While these findings suggest that subicular pyramidal cell dendrites may be structurally altered in subjects with schizophrenia, this possibility had not been tested directly.

Methods  Rapid Golgi impregnation of archival brain specimens was used to compare the morphologic characteristics of subicular dendrites in subjects with schizophrenia (n=13) and mood disorders (n=6) with subjects without psychiatric disease (n=8). The specimens were processed and analyzed by physicians blind to diagnosis. The extent of dendritic trees in the subiculum and fusiform gyrus was examined by Sholl analysis. Spine density on apical dendrites of subicular pyramidal cells was determined at a fixed distance from the cell body.

Results  Spine density and arborization of subicular apical dendrites were significantly related to diagnostic group. Spine density was significantly lower in the schizophrenia and mood disorder groups than in the nonpsychiatric group. Among the mood disorder cases, diminished spine density was apparently related to a strong family history of major psychiatric diseases. There were no significant effects of diagnostic group on Sholl analysis of nonapical subicular dendrites nor on Sholl analysis of dendrites of neocortical pyramidal cells in the fusiform gyrus.

Conclusions  We have observed an association between schizophrenia and major mood disorders and structural abnormalities of subicular apical dendrites. Further studies are needed to test this association in a larger sample and to evaluate the potential role of family history and of confounding factors, such as medications and chronic institutionalization.


From the Departments of Psychiatry, Division of Neuroscience (Drs Rosoklija, Mann, and Dwork), Neurology (Dr Latov), and Pathology, Division of Neuropathology (Drs Hays and Dwork), College of Physicians & Surgeons of Columbia University, New York, NY; Duke University School of Medicine (Mr Toomayan), Durham, NC; and the Department of Neuroscience, Division of Neuropathology (Drs Ellis, Keilp, and Dwork), and the Schizophrenia Research Unit (Dr Dwork), New York State Psychiatric Institute, New York.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

How High-Resolution Basal-State Functional Imaging Can Guide the Development of New Pharmacotherapies for Schizophrenia
Gaisler-Salomon et al.
Schizophr Bull 2009;35:1037-1044.
ABSTRACT | FULL TEXT  

Dysconnection in Schizophrenia: From Abnormal Synaptic Plasticity to Failures of Self-monitoring
Stephan et al.
Schizophr Bull 2009;35:509-527.
ABSTRACT | FULL TEXT  

Type III Neuregulin-1 Is Required for Normal Sensorimotor Gating, Memory-Related Behaviors, and Corticostriatal Circuit Components
Chen et al.
J. Neurosci. 2008;28:6872-6883.
ABSTRACT | FULL TEXT  

Hippocampal Morphology and Distinguishing Late-Onset From Early-Onset Elderly Depression
Ballmaier et al.
Am. J. Psychiatry 2008;165:229-237.
ABSTRACT | FULL TEXT  

Review: Glutamate and dopamine dysregulation in schizophrenia a synthesis and selective review
Stone et al.
J Psychopharmacol 2007;21:440-452.
ABSTRACT  

The Neuropsychiatry of Niemann-Pick Type C Disease in Adulthood
Walterfang et al.
J. Neuropsychiatry Clin. Neurosi. 2006;18:158-170.
ABSTRACT | FULL TEXT  

Chromatin Alterations Associated With Down-regulated Metabolic Gene Expression in the Prefrontal Cortex of Subjects With Schizophrenia
Akbarian et al.
Arch Gen Psychiatry 2005;62:829-840.
ABSTRACT | FULL TEXT  

Constitutively Active Cytoplasmic c-Jun N-Terminal Kinase 1 Is a Dominant Regulator of Dendritic Architecture: Role of Microtubule-Associated Protein 2 as an Effector
Bjorkblom et al.
J. Neurosci. 2005;25:6350-6361.
ABSTRACT | FULL TEXT  

Structural Brain Magnetic Resonance Imaging of Limbic and Thalamic Volumes in Pediatric Bipolar Disorder
Frazier et al.
Am. J. Psychiatry 2005;162:1256-1265.
ABSTRACT | FULL TEXT  

Reduced Spinophilin in Schizophrenia
DWORK et al.
Am. J. Psychiatry 2005;162:1389-1389.
FULL TEXT  

Reduced Spinophilin But Not Microtubule-Associated Protein 2 Expression in the Hippocampal Formation in Schizophrenia and Mood Disorders: Molecular Evidence for a Pathology of Dendritic Spines
Law et al.
Am. J. Psychiatry 2004;161:1848-1855.
ABSTRACT | FULL TEXT  

Amygdala and Hippocampal Volumes in Adolescents and Adults With Bipolar Disorder
Blumberg et al.
Arch Gen Psychiatry 2003;60:1201-1208.
ABSTRACT | FULL TEXT  

Depression: What We can Learn from Postmortem Studies
Rajkowska
Neuroscientist 2003;9:273-284.
ABSTRACT  

Epigenetic Downregulation of GABAergic Function in Schizophrenia: Potential for Pharmacological Intervention?
Costa et al.
Mol. Interv. 2003;3:220-229.
ABSTRACT | FULL TEXT  

High-Dimensional Mapping of the Hippocampus in Depression
Posener et al.
Am. J. Psychiatry 2003;160:83-89.
ABSTRACT | FULL TEXT  

An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability
Tremolizzo et al.
Proc. Natl. Acad. Sci. USA 2002;99:17095-17100.
ABSTRACT | FULL TEXT  

Stress and the progression of the developmental hypothesis of schizophrenia
COTTER and PARIANTE
Br. J. Psychiatry 2002;181:363-365.
FULL TEXT  

The neuropathology of primary mood disorder
Harrison
Brain 2002;125:1428-1449.
ABSTRACT | FULL TEXT  

REELIN and Schizophrenia:: A Disease at the Interface of the Genome and the Epigenome
Costa et al.
Mol. Interv. 2002;2:47-57.
ABSTRACT | FULL TEXT  

Reduced Glial Cell Density and Neuronal Size in the Anterior Cingulate Cortex in Major Depressive Disorder
Cotter et al.
Arch Gen Psychiatry 2001;58:545-553.
ABSTRACT | FULL TEXT  

Neuropathological abnormalities in schizophrenia: evidence from magnetization transfer imaging
Foong et al.
Brain 2001;124:882-892.
ABSTRACT | FULL TEXT  

Down-regulation of dendritic spine and glutamic acid decarboxylase 67 expressions in the reelin haploinsufficient heterozygous reeler mouse
Liu et al.
Proc. Natl. Acad. Sci. USA 2001;98:3477-3482.
ABSTRACT | FULL TEXT  

An End to Kraepelinian Nosology?
Ovsiew
J. Neuropsychiatry Clin. Neurosi. 2000;12:297-299.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2000 American Medical Association. All Rights Reserved.